| FISHERS, Ind., Dec. 19, 2011 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), a leading molecular imaging company specializing in the field of nuclear cardiology is pleased to announce that on December 16, 2011, the Company received a nuclear pharmacy license from the Indiana Board of Pharmacy for the Company's Crown Point, Indiana manufacturing facility. The Indiana Board of Pharmacy license completes the requirements necessary to amend its NRC license to allow Positron to manufac...continued POSC oncology imaging perfusion |
Monday, December 19, 2011
Positron Recieves Indiana Board of Pharmacy License
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment